Company / Profit Margin
NeoGenomics Laboratories, Inc. Profit Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-0.6%
FY2017
5-year range
-
FY2016-FY2017
Trend
+74.6%
vs FY2016
Sector context
#100 of 156
Health Care
What the data says
At -0.6%, NeoGenomics Laboratories, Inc.'s profit margin ranks #100 of 156 in the Health Care sector.
Based on SEC 10-K filings.
-0.6% in FY2017.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#100 of 156 in Health CareTop 64% of 156This company -0.6% Sector average -252.5%
▼
+99.7% above sector average
Key checks
Key Insights
- In FY2017, profit margin increased 74.6% year-over-year.
- Currently 251.9pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -0.6% | +74.6% |
| FY2016 | -2.5% | +95.0% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026